Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Outcomes and prognosis news

Show

From To
For women, HIV treatment based on atazanavir/ritonavir involves twice the risk of failure compared to efavirenz-containing therapy

Treatment outcomes differ between women taking first-line antiretroviral therapy based on ritonavir-boosted atazanavir and efavirenz, investigators from the United States report in the online edition of Clinical Infectious Diseases.

Published
04 December 2013
By
Michael Carter
Micronutrient supplements delay HIV disease progression for patients with higher CD4 cell counts

Long-term micronutrient supplementation delays HIV disease progression in people with higher CD4 cell counts, results of a study published in the Journal of the American Medical Association shows.

Published
28 November 2013
By
Michael Carter
How much longer have I got?

We’re concentrating on the future as a theme in this, the last-ever HIV treatment update. So it seems appropriate to have an update on exactly how much

Published
25 November 2013
From
HIV treatment update
Systematic review and meta-analysis shows equivalence of 3TC and FTC

The nucleoside reverse transcriptase inhibitors (NRTIs) 3TC and FTC are equally effective, results of a meta-analysis and systematic review published in PLOS ONE show. Pooled results from twelve

Published
20 November 2013
By
Michael Carter
HIV may be becoming less fit as it adapts to the immune system

HIV, at least in some parts of the world, may be developing a lower replicative capacity as it adapts to variations in the human immune system, studies

Published
08 November 2013
By
Gus Cairns
HIV rebound linked to higher baseline level, slower suppression and low-level viraemia

Higher baseline viral load, longer time to viral suppression and low-level viraemia below the level of detection of standard tests raise the risk of viral rebound amongst

Published
31 October 2013
By
Liz Highleyman
Social problems and drug and alcohol problems common among people who develop AIDS despite long-term HIV care

Psychiatric, drug, alcohol and social care problems are highly prevalent among people who develop serious AIDS-defining illnesses well after their diagnosis with HIV, UK research published in Sexually Transmitted

Published
25 October 2013
By
Michael Carter
Big differences in virological outcomes among people taking first-line HIV therapy in resource-limited settings

Virological outcomes vary enormously among people taking antiretroviral therapy in different resource-limited settings, according to research published in the online edition of Clinical Infectious Diseases. An international team of

Published
16 October 2013
By
Michael Carter
People with HIV have higher risk of death after heart attack

People with HIV had higher mortality than HIV-negative individuals after hospitalisation for acute coronary syndrome, but the excess risk disappeared for people on antiretroviral therapy with high CD4

Published
08 October 2013
By
Liz Highleyman
Liver fibrosis linked to immune activation in HIV/HCV co-infected women

CD4 and CD8 cell activation were found to be associated with biomarkers of liver fibrosis among HIV/HCV co-infected women, suggesting that immune activation related to persistent HIV infection

Published
07 October 2013
By
Liz Highleyman

Filter by country